Patents by Inventor Laurel J. Mengle-Gaw

Laurel J. Mengle-Gaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8222267
    Abstract: A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents, a one-hour average oral morphine equivalents, or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.
    Type: Grant
    Filed: July 18, 2011
    Date of Patent: July 17, 2012
    Assignee: QRxPharma Ltd.
    Inventors: Patricia T. Richards, Warren C. Stern, Laurel J. Mengle-Gaw, Benjamin Schwartz
  • Publication number: 20120041014
    Abstract: A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents, a one-hour average oral morphine equivalents, or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.
    Type: Application
    Filed: July 18, 2011
    Publication date: February 16, 2012
    Inventors: Patricia T. RICHARDS, Warren C. Stern, Laurel J. Mengle-Gaw, Benjamin Schwartz
  • Patent number: 8012990
    Abstract: A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: September 6, 2011
    Assignee: QRxPharma Ltd.
    Inventors: Patricia T. Richards, Warren C. Stern, Laurel J. Mengle-Gaw, Benjamin D. Schwartz
  • Publication number: 20110086873
    Abstract: A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.
    Type: Application
    Filed: September 14, 2010
    Publication date: April 14, 2011
    Inventors: Patricia T. Richards, Warren C. Stern, Laurel J. Mengle-Gaw, Benjamin D. Schwartz
  • Publication number: 20110086874
    Abstract: A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.
    Type: Application
    Filed: September 14, 2010
    Publication date: April 14, 2011
    Inventors: Patricia T. Richards, Warren C. Stern, Laurel J. Mengle-Gaw, Benjamin Schwartz
  • Patent number: 7923453
    Abstract: A method of converting a treatment for pain comprising intravenous administration of opioids, to a treatment for pain comprising oral administration of a first dose of an immediate release morphine-oxycodone combination in patients in need of analgesia. The method may comprise (1) determining a four-hour average oral morphine equivalents or determining a net average hourly intravenous dose, and (2) orally administering to the patient a first dose of a morphine-oxycodone combination in a 3:2 ratio by weight every four to six hours. Also, a method of treating pain in patients who had been administered opioids intravenously, comprising using a dosing algorithm to determine the first dose of the immediate release morphine-oxycodone combination.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: April 12, 2011
    Assignee: QRxPharma Ltd.
    Inventors: Patricia T. Richards, Warren C. Stern, Laurel J. Mengle-Gaw, Benjamin D. Schwartz